According to STAAR Surgical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.4286. At the end of 2022 the company had a P/E ratio of 59.9.
Year | P/E ratio | Change |
---|---|---|
2022 | 59.9 | -65.87% |
2021 | 176 | -74.06% |
2020 | 677 | 496.72% |
2019 | 113 | -64.45% |
2018 | 319 | -189.24% |
2017 | -358 | 869.18% |
2016 | -36.9 | -17.32% |
2015 | -44.6 | 12.66% |
2014 | -39.6 | -102.45% |
2013 | > 1000 | -1227.46% |
2012 | -144 | -141.07% |
2011 | 350 | -100% |
2010 | > 1000 | -1.134325996468E+19% |
2009 | -15.5 | 414.5% |
2008 | -3.01 | -33.81% |
2007 | -4.55 | -60.39% |
2006 | -11.5 | -31.63% |
2005 | -16.8 | 55.49% |
2004 | -10.8 | -56.8% |
2003 | -25.0 | 564.55% |
2002 | -3.77 | -13.94% |
2001 | -4.38 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | 2.67 | -93.70% | ๐บ๐ธ USA |
![]() | 14.9 | -64.87% | ๐บ๐ธ USA |
![]() | 29.9 | -29.43% | ๐บ๐ธ USA |
![]() | 42.3 | -0.31% | ๐บ๐ธ USA |
![]() | 29.2 | -31.25% | ๐จ๐ญ Switzerland |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.